Gli-fully Halting the Progression of Fibrosis
Christian F. Guerrero-Juarez, Maksim V. Plikus
Index: 10.1016/j.stem.2017.05.003
Full Text: HTML
Abstract
Activating triggers, selective markers, and the residual regenerative potential of scar-forming myofibroblasts are largely determined by their origin. In this issue ofCell Stem Cell, Schneider et al. report that bone marrow myofibroblasts derive from Gli1+mesenchymal stromal cells and that a Gli inhibitor targets them for elimination in mice and humans, ameliorating fibrosis.
Latest Articles:
2017-07-13
[10.1016/j.stem.2017.06.004]
Lineage Tracing: Papers and Progress
2017-07-06
[10.1016/j.stem.2017.06.015]
Intestinal Enteroendocrine Lineage Cells Possess Homeostatic and Injury-Inducible Stem Cell Activity
2017-07-06
[10.1016/j.stem.2017.06.014]
Direct Neuronal Reprogramming: Achievements, Hurdles, and New Roads to Success
2017-07-06
[10.1016/j.stem.2017.06.011]
Making HSCs on Demand: Looking Ahead
2017-07-06
[10.1016/j.stem.2017.06.010]